Prevalence of sarcoidosis in Switzerland is associated with environmental factors

European Respiratory Journal

Volumn 35, Issue 5, 2010, Pages 1088-1097

  Deubelbeiss, U ^a,c   Gemperli, A ^b   Schindler, C ^b   Baty, F ^a   Brutsche, M H ^a,c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c Kantonsspital St Gallen ^*  (Switzerland)

Author keywords

Agriculture; Air pollution; Berylliosis; Epidemiology; Metal industry

Indexed keywords

AGRICULTURE; AIR POLLUTION; AIR QUALITY; ARTICLE; BREAD; CONTROLLED STUDY; CORRELATION ANALYSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; GEOGRAPHIC DISTRIBUTION; GRASSLAND; HEALTH CARE PLANNING; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METAL INDUSTRY; POPULATION DENSITY; POTATO; PREVALENCE; PRIORITY JOURNAL; SARCOIDOSIS; SWITZERLAND; WATER SUPPLY;

ENVIRONMENTAL EXPOSURE; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; LINEAR MODELS; MALE; MIDDLE AGED; MONTE CARLO METHOD; PREVALENCE; RISK FACTORS; SARCOIDOSIS; SWITZERLAND;

EID: 77951941821     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00197808     Document Type: Article

References (42)

1. Fernandez Fabrellas E. [Epidemiology of sarcoidosis.] Arch Bronconeumol 2007; 43: 92-100.
2. Wiegand JA, Brutsche MH. Sarcoidosis is a multisystem disorder with variable prognosis - information for treating physicians. Swiss Med Wkly 2006; 136: 203-209.
3. Barnard J, Rose C, Newman L, et al. Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS). J Occup Environ Med 2005; 47: 226-234. (Pubitemid 40365760)
4. Kucera GP, Rybicki BA, Kirkey KL, et al.Occupational risk factors for sarcoidosis in African-American siblings. Chest 2003; 123: 1527-1535. (Pubitemid 36549772)
5. Prezant DJ, Dhala A, Goldstein A, et al. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest 1999; 116: 1183-1193. (Pubitemid 29535967)
6. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
7. Muller-Quernheim J, Gaede KI, Fireman E, et al. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J 2006; 27: 1190-1195. (Pubitemid 44914303)
8. Muller-Quernheim J, Rubin R, Leimer L, et al. [Macrophage function in sarcoidosis. I. Suppressed oxidative metabolism of macrophages in sarcoidosis in correlation with inflammation.] Prax Klin Pneumol 1983; 37: 1130-1133.
9. Anantham D, Ong SJ, Chuah KL, et al. Sarcoidosis in Singapore: epidemiology, clinical presentation and ethnic differences. Respirology 2007; 12: 355-360. (Pubitemid 47164777)
10. Chapelon-Abric C. [Epidemiology of sarcoidosis and its genetic and environmental risk factors.] Rev Med Interne 2004; 25: 494-500.
11. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-173.
12. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336: 1224-1234.
13. Thomas KW, Hunninghake GW. Sarcoidosis. JAMA 2003; 289: 3300-3303.
14. Hiraga Y. [An epidemiological study of clustering of sarcoidosis cases.] Nippon Rinsho 1994; 52: 1438-1442.
15. Pietinalho A, Ohmichi M, Hirasawa M, et al. Familial sarcoidosis in Finland and Hokkaido, Japan - a comparative study. Respir Med 1999; 93: 408-412.
16. NOGA. General Classification of Economic Activities. Federal Statistical Office, Neuchâtel, 2002. Available from: www.bfs.admin.ch/bfs/portal/en/ index/infothek/nomenklaturen/blank/blank/noga0/publikationen.Document.48936.pdf
17. Liu LJ, Curjuric I, Keidel D, et al. Characterization of sourcespecific air pollution exposure for a large population-based Swiss cohort (SAPALDIA). Environ Health Perspect 2007; 115: 1638-1645.
18. Ackermann-Liebrich U, Meier C, Paccaud F, et al., Methoden und Grundlagen., In: Gutzwiller F, Paccaud F, eds. Social and Preventative Medicine. Verlag Hans Huber, Bern, 2007; p 42.
19. Viskum K, Vestbo J. [Sarcoidosis. Dependence of life expectancy on lung function, respiratory symptoms, roentgenologic stage and age at diagnosis and significance of extrapulmonary manifestations.] Versicherungsmedizin 1995; 47: 221-223.
20. Viskum K, Vestbo J. Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J 1993; 6: 349-353. (Pubitemid 23114879)
21. [Population Size and Population Composition]. Federal Statistical Office, Neuchâtel 2008. Available from: www.bfs.admin.ch/bfs/portal/de/index/ news/publikationen.Document.111689.pdf
22. Dray S, Chessel D, Thioulouse J. Co-inertia analysis and the linking of egological data tables. Ecology 2003; 84: 3078-3089. (Pubitemid 38261454)
23. James DG. Epidemiology of sarcoidosis. Sarcoidosis 1992; 9: 79-87.
24. Reid JD. Sarcoidosis in coroner's autopsies: a critical evaluation of diagnosis and prevalence from Cuyahoga County, Ohio. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 44-51.
25. Byg KE, Milman N, Hansen S. Sarcoidosis in Denmark 1980-1994. A registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 46-52.
26. Pietinalho A, Hiraga Y, Hosoda Y, et al. The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. Sarcoidosis 1995; 12: 61-67.
27. Alilovic M, Peros-Golubicic T, Tekavec-Trkanjec J, et al. Prevalence of hospitalized patients with sarcoidosis in Croatia. Coll Antropol 2004; 28: 423-428. (Pubitemid 38901308)
28. McKenna J, Ibrahim A. Isolated common peroneal nerve palsy in sarcoidosis. Ir Med J 2008; 101: 313-314.
29. Reynolds HY. Sarcoidosis: impact of other illnesses on the presentation and management of multi-organ disease. Lung 2002; 180: 281-299.
30. Uygun S, Yanardag H, Karter Y, et al. Course and prognosis of sarcoidosis in a referral setting in Turkey; analysis of 166 patients. Acta Medica (Hradec Kralove) 2006; 49: 51-57.
31. Chung YM, Lin YC, Huang DF, et al. Conjunctival biopsy in sarcoidosis. J Chin Med Assoc 2006; 69: 472-477.
32. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164: 1885-1889 (Pubitemid 33152325)
33. Fireman E, Kramer MR, Priel I, et al. Chronic beryllium disease among dental technicians in Israel. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23: 215-221. (Pubitemid 47596317)
34. Kreider ME, Christie JD, Thompson B, et al. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 2005; 128: 207-215. (Pubitemid 40994475)
35. Seiler E. [On the epidemiology of sarcoidosis (Boeck's disease) in Switzerland. Statistical research on the geographical and occupational distribution of 108 military patients with sarcoidosis]. Schweiz Z Tuberc Pneumonol 1960; 17: 205-228.
36. Yigla M, Badarna-Abu-Ria N, Tov N, et al. Sarcoidosis in northern Israel; clinical characteristics of 120 patients. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 220-226.
37. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004; 170: 1324-1330. (Pubitemid 39657197)
38. Redlich CA, Welch LS. Chronic beryllium disease: risk from lowlevel exposure. Am J Respir Crit Care Med 2008; 177: 936-937. (Pubitemid 351717583)
39. Maier LA, Martyny JW, Liang J, et al. Recent chronic beryllium disease in residents surrounding a beryllium facility. Am J Respir Crit Care Med 2008; 177: 1012-1017. (Pubitemid 351717596)
40. Hardy HL. Delayed chemical pneumonitis in workers exposed to beryllium compounds. Am Rev Tuberc 1948; 57: 547-556.
41. Machle W. Berylliosis; observations and report of clinical study of 70 cases of chronic disease. J Lab Clin Med 1948; 33: 1613.
42. Swiss External Trade, Tariff Headings, Import and Export Tares. Federal Customs Administration, Federal Department of Finance. Switzerland, 2002-2007. www.ezv.admin.ch/pdf-linker.php?doc5Tares-d6-81